According to the latest data from the Hong Kong Stock Exchange, on February 4, Norges Bank sold 1,834,200 shares of Pharmaron (03759) at a price of HK$20.4681 per share. The total value of the transaction was approximately HK$37.54 million. Following this reduction, the bank's shareholding in the company stands at approximately 20.74 million shares, representing a stake of 5.88%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.